MP

Michael Panaccio

ReNerve Limited | Non-Executive Director
Mr Panaccio is one of the founders of Starfish Ventures, a venture capital firm that invests in early stage technology companies and plays an active role in the management of its portfolio. Michael has been a director of numerous technology businesses in Australia and the USA including SIRTeX Medical Ltd, Engana Pty Ltd (acquired by Optium Inc), Energy Response (sold to EnerNoc Inc), ImpediMed Ltd, and Protagonist Therapeutics Inc. He currently serves on the boards of MetaCDN Pty Ltd, Margin Clear Pty Ltd, Marp Therapeutics Pty Ltd and Cylite Pty Ltd. Dr Panaccio will be a non executive Director.

Company and Role

Company
Title
Tenure
Since
RNV
RNV
ReNerve Limited
  • Non-Executive Director
7yrs, 2mthApr 2018

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RNV
RNV
ReNerve Limited
13/02/25631,0003,031,250N/AN/A
DVL
DVL
30/06/24101,191,008N/A11,191,109N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RNV
RNV
ReNerve Limited
13/02/25
Buy
100,000$0.160$16,000On-market trade
DVL
DVL
06/10/23
Issued
1,000,001$0.011$11,000Issue of options
DVL
DVL
03/07/23
Issued
1,000,001$0.011$11,000Issue of options
DVL
DVL
03/04/23
Issued
733,334$0.001$1,100Issue of options
DVL
DVL
03/01/23
Issued
916,668$0.001$1,100Issue of options